Abstract
We present the finding of a dimeric ACE2 peptide mimetic designed through side chain cross-linking and covalent dimerization. It has a binding affinity of 16 nM for the SARS-CoV-2 spike RBD, and effectively inhibits the SARS-CoV-2 pseudovirus in Huh7-hACE2 cells with an IC50 of 190 nM and neutralizes the authentic SARS-CoV-2 in Caco2 cells with an IC50 of 2.4 μM. Our study should provide a new insight for the optimization of peptide-based anti-SARS-CoV-2 inhibitors.
MeSH terms
-
Amino Acid Sequence
-
Angiotensin-Converting Enzyme 2 / chemistry
-
Antiviral Agents / chemical synthesis
-
Antiviral Agents / metabolism
-
Antiviral Agents / pharmacology*
-
Cell Line, Tumor
-
Humans
-
Microbial Sensitivity Tests
-
Peptide Fragments / chemical synthesis
-
Peptide Fragments / metabolism
-
Peptide Fragments / pharmacology*
-
Peptidomimetics / chemical synthesis
-
Peptidomimetics / metabolism
-
Peptidomimetics / pharmacology*
-
Protein Binding
-
Protein Domains
-
SARS-CoV-2 / drug effects*
-
Spike Glycoprotein, Coronavirus / chemistry
-
Spike Glycoprotein, Coronavirus / metabolism
Substances
-
Antiviral Agents
-
Peptide Fragments
-
Peptidomimetics
-
Spike Glycoprotein, Coronavirus
-
spike protein, SARS-CoV-2
-
ACE2 protein, human
-
Angiotensin-Converting Enzyme 2